226 related articles for article (PubMed ID: 12540618)
1. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
Aasum E; Hafstad AD; Severson DL; Larsen TS
Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
[TBL] [Abstract][Full Text] [Related]
2. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
[TBL] [Abstract][Full Text] [Related]
3. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
Belke DD; Larsen TS; Gibbs EM; Severson DL
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
[TBL] [Abstract][Full Text] [Related]
4. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
5. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
[TBL] [Abstract][Full Text] [Related]
6. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator.
Aasum E; Belke DD; Severson DL; Riemersma RA; Cooper M; Andreassen M; Larsen TS
Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H949-57. PubMed ID: 12181123
[TBL] [Abstract][Full Text] [Related]
7. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
[TBL] [Abstract][Full Text] [Related]
8. High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery.
Gonsolin D; Couturier K; Garait B; Rondel S; Novel-Chaté V; Peltier S; Faure P; Gachon P; Boirie Y; Keriel C; Favier R; Pepe S; Demaison L; Leverve X
Mol Cell Biochem; 2007 Jan; 295(1-2):217-28. PubMed ID: 16944307
[TBL] [Abstract][Full Text] [Related]
9. Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin.
Hafstad AD; Solevåg GH; Severson DL; Larsen TS; Aasum E
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1763-9. PubMed ID: 16327015
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts.
Liu Q; Clanachan AS; Lopaschuk GD
Am J Physiol; 1998 Sep; 275(3):E392-9. PubMed ID: 9725804
[TBL] [Abstract][Full Text] [Related]
11. Effect of nutritional state on substrate metabolism and contractile function in postischemic rat myocardium.
Montessuit C; Papageorgiou I; Tardy I; Lerch R
Am J Physiol; 1996 Nov; 271(5 Pt 2):H2060-70. PubMed ID: 8945926
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
How OJ; Larsen TS; Hafstad AD; Khalid A; Myhre ES; Murray AJ; Boardman NT; Cole M; Clarke K; Severson DL; Aasum E
Arch Physiol Biochem; 2007; 113(4-5):211-20. PubMed ID: 18158644
[TBL] [Abstract][Full Text] [Related]
13. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
[TBL] [Abstract][Full Text] [Related]
14. Suppression of 5'-AMP-activated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts.
Folmes CD; Wagg CS; Shen M; Clanachan AS; Tian R; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H313-21. PubMed ID: 19429810
[TBL] [Abstract][Full Text] [Related]
15. Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts.
Madden MC; Wołkowicz PE; Pohost GM; McMillin JB; Pike MM
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2505-12. PubMed ID: 7611501
[TBL] [Abstract][Full Text] [Related]
16. Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts.
Banke NH; Lewandowski ED
J Mol Cell Cardiol; 2015 Feb; 79():13-20. PubMed ID: 25450611
[TBL] [Abstract][Full Text] [Related]
17. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion.
Vanoverschelde JL; Janier MF; Bakke JE; Marshall DR; Bergmann SR
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1785-94. PubMed ID: 7977809
[TBL] [Abstract][Full Text] [Related]
18. Effect of gender and fatty acids on ischemic recovery of contractile and pump function in the rat heart.
Broderick TL; Glick B
Gend Med; 2004 Dec; 1(2):86-99. PubMed ID: 16115587
[TBL] [Abstract][Full Text] [Related]
19. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
Neitzel AS; Carley AN; Severson DL
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E357-65. PubMed ID: 12397026
[TBL] [Abstract][Full Text] [Related]
20. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED
Diabetes; 2004 Sep; 53(9):2366-74. PubMed ID: 15331547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
